FBT

Equity ETFs

Biotech ETFs Climb on Biogen’s Promising Clinical Trial

By Max ChenJuly 6, 2018

Equity ETFs

Alkermes FDA Refusal: Biotech ETFs Dragged Down

By Max ChenApril 2, 2018

Equity ETFs

Biotech ETFs Pop on Celgene, Juno Deal

By Max ChenJanuary 22, 2018

Equity ETFs

Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare

By Max ChenJanuary 4, 2017

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

Why Trump Can Boost Biotech ETFs

By Tom LydonNovember 16, 2016

Equity ETFs

Taking the Technical Temperature of Biotech ETFs

By Tom LydonOctober 21, 2016

Equity ETFs

Another Endorsement for Biotech ETFs

By Tom LydonAugust 16, 2016

Equity ETFs

Biotech ETFs: Will the Once Hot Group Rebound?

By Tom LydonJuly 13, 2016

Equity ETFs

Expect More Election Year Volatility For Biotech ETFs

By Tom LydonJune 21, 2016

Equity ETFs

A Catalyst for Biotech ETFs

By Brenton GarenJune 6, 2016

Equity ETFs

Trying to Believe in Biotech ETFs

By Brenton GarenJune 3, 2016

Equity ETFs

Finally A Biotech ETF Bounce?

By Brenton GarenJune 1, 2016

Featured

15 Most Read ETF Articles of the Week (May 16-20)

By Brenton GarenMay 20, 2016

Equity ETFs

Resisting the Temptation of Biotech ETFs

By Brenton GarenMay 16, 2016

Equity ETFs

10 Best & Worst ETF Performers of the Day (May 11)

By Brenton GarenMay 11, 2016

Currency-Hedged

ETF TMI: 2 Themed ETFs Launch; Energy, MLPs Active

By Brenton GarenMay 10, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016